HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Masuma Akter Monty Selected Research

CD7 Antigens

3/2022Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Masuma Akter Monty Research Topics

Disease

3Neoplasms (Cancer)
03/2022 - 10/2020
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
03/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2022
1Multiple Myeloma
01/2022
1Communicable Diseases (Infectious Diseases)
01/2021
1Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021
1Hepatocellular Carcinoma (Hepatoma)
10/2020

Drug/Important Bio-Agent (IBA)

2Chimeric Antigen ReceptorsIBA
03/2022 - 01/2022
1CD7 AntigensIBA
03/2022
1MicroRNAs (MicroRNA)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
01/2021
1Small Interfering RNA (siRNA)IBA
01/2021
1Interleukin-17 (Interleukin 17)IBA
10/2020
1Immunoglobulin FragmentsIBA
10/2020

Therapy/Procedure

2Immunotherapy
03/2022 - 01/2021